Addictions CAG Publications 2019 Jan to Feb
Ashdown-Franks G. Stubbs B. Koyanagi A. Schuch F. Firth J. Veronese N. Vancampfort D. (2019). Handgrip strength and depression among 34,129 adults aged 50 years and older in six low- and middle-income countries. Journal of Affective Disorders. 243:448-454. doi: 10.1016/j.jad.2018.09.036.
Bailey K. Trevillion K. Gilchrist G. (2019). What works for whom and why: A narrative systematic review of interventions for reducing post-traumatic stress disorder and problematic substance use among women with experiences of interpersonal violence. Journal of Substance Abuse Treatment. 99:88-103. doi: 10.1016/j.jsat.2018.12.007.
Borland R. Murray K. Gravely S. Fong G.T. Thompson M.E. McNeill A. O'Connor R.J. Goniewicz M.L. Yong H.H. Levy D.T. Heckman B.W. Cummings K.M. (2019). A new classification system for describing concurrent use of nicotine vaping products alongside cigarettes (so-called "dual use"): Findings from the ITC-4 Country Smoking and Vaping Wave 1 Survey t. Addiction. doi: 10.1111/add.14570. [Epub ahead of print].
Braak D.C. Cummings K.M. Nahhas G.J. Heckman B.W. Borland R. Fong G.T. Hammond D. Boudreau C. McNeill A. Levy D.T. Shang C. (2019). Where do vapers buy their vaping supplies? Findings from the International Tobacco Control (ITC) 4 Country Smoking and Vaping Survey. International Journal of Environmental Research and Public Health. 16(3). pii: E338. doi: 10.3390/ijerph16030338.
Brennan A. Hill-McManus D. Stone T. Buykx P. Ally A. Pryce R.E. Alston R. Jones A. Cairns D. Millar T. Donmall M. Phillips T. Meier P. Drummond C. (2019). Modeling the potential impact of changing access rates to specialist treatment for alcohol dependence for local authorities in England: The Specialist Treatment for Alcohol Model (STreAM). Journal of Studies on Alcohol and Other Drugs. Sup 18:96-109.
Brose L.S. Simonavicius E. McNeill A. (2019). Rejoinder relating to correspondence by Dr Eleanor Woodward, Professor Robyn Richmond on Brose LS, Simonavicius E, McNeill A (2018). Maintaining abstinence from smoking after a period of enforced abstinence. Psychological Medicine. 49(2):347-348. doi: 10.1017/S0033291718003410.
Chan G.C.K. Leung J. Hall W. (2019). Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates. Drug and Alcohol Review. 38(2):151-158. doi: 10.1111/dar.12893.
Chan G. Leung J. Gartner C. Yong H.H. Borland R. Hall W. (2019). Correlates of electronic cigarette use in the general population and among smokers in Australia - Findings from a nationally representative survey. Addictive Behaviors. 95:6-10. doi: 10.1016/j.addbeh.2019.02.012.
Chan G.C.K. Butterworth P. Becker D. Degenhardt L. Stockings E. Hall W. Patton G. (2019). Longitudinal patterns of amphetamine use from adolescence to adulthood: A latent class analysis of a 20-year prospective study of Australians. Drug and Alcohol Dependence.194:121-127. doi: 10.1016/j.drugalcdep.2018.08.042.
Chandra S. Radwan M.M. Majumdar C.G. Church J.C. Freeman T.P. ElSohly M.A. (2019). New trends in cannabis potency in USA and Europe during the last decade (2008-2017). European Archives of Psychiatry and Clinical Neuroscience. doi: 10.1007/s00406-019-00983-5. [Epub ahead of print].
Day E. Broder T. Bruneau J. Cruse S. Dickie M. Fish S. Grillon C. Luhmann N. Mason K. McLean E. Trooskin S. Treloar C. Grebely J. (2019). Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs. International Journal of Drug Policy. 66:87-93. doi: 10.1016/j.drugpo.2019.01.012.
Day E. Hellard M. Treloar C. Bruneau J. Martin N.K. Øvrehus A. Dalgard O. Lloyd A. Dillon J. Hickman M. Byrne J. Litwin A. Maticic M. Bruggmann P. Midgard H. Norton B. Trooskin S. Lazarus J.V. Grebely J. International Network on Hepatitis in Substance Users (INHSU). (2019). Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework. Liver International. 39(1):20-30. doi: 10.1111/liv.13949.
Drummond C. (2019). Addiction treatment: Who needs it? Journal of Studies on Alcohol and Other Drugs. Sup 18:110-111. doi: 10.15288/jsads.2019.s18.110
Eastwood B. Strang J. Marsden J. (2019). Change in alcohol and other drug use during five years of continuous opioid substitution treatment. Drug and Alcohol Dependence. 194:438-446. doi:10.1016/j.drugalcdep.2018.11.008.
Farrugia A. Fraser S. Dwyer R. Fomiatti R. Neale J. Dietze P. Strang J. (2019). Take-home naloxone and the politics of care. Sociology of Health and Illness. 41(2):427-443. doi: 10.1111/1467-9566.12848.
Grebely J. Larney S. Peacock A. Colledge S. Leung J. Hickman M. Vickerman P. Blach S. Cunningham E.B. Dumchev K. Lynskey M. Stone J. Trickey A. Razavi H. Mattick R.P. Farrell M. Dore G.J. Degenhardt L. (2019). Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction. 114(1):150-166. doi: 10.1111/add.14393.
Hall W. Hoch E. Lorenzetti V. (2019). Cannabis use and mental health: risks and benefits. European Archives of Psychiatry and Clinical Neuroscience. doi: 10.1007/s00406-019-00986-2. [Epub ahead of print].
Kalk N.J. (2019). Harm reduction in opioid treatment: an established idea under threat. Addiction. 114(1):20-21. doi: 10.1111/add.14468.
Karcher N.R. Barch D.M. Demers C.H. Baranger D.A.A. Heath A.C. Lynskey M.T. Agrawal A. (2019). Genetic predisposition vs individual-specific processes in the association between psychotic-like experiences and cannabis use. JAMA Psychiatry. 76(1):87-94. doi: 10.1001/jamapsychiatry.2018.2546.
Lane T.J. Hall W. (2019). Traffic fatalities within US states that have legalized recreational cannabis sales and their neighbours. Addiction. doi: 10.1111/add.14536. [Epub ahead of print].
Larney S, Hall W. (2019). A major expansion of opioid agonist treatment is needed to reduce overdose deaths in the USA. Lancet Public Health. 4(2):e77-e78. doi: 10.1016/S2468-2667(19)30001-5.
Lee H.S. Wilson S. Partos T. McNeill A. Brose L.S. (2019).Awareness of changes in e-cigarette regulations and behaviour before and after implementation: A longitudinal survey of smokers, ex-smokers and vapers in the United Kingdom. Nicotine and Tobacco Research. doi: 10.1093/ntr/ntz008. [Epub ahead of print].
Leung J. Peacock A. Colledge S. Grebely J. Cunningham E.B. Hickman M. Vickerman P. Stone J. Trickey A. Dumchev K. Lynskey M. Hines L. Griffiths P. Mattick R.P. Degenhardt L. Larney S. (2019). A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators? Journal of Infectious Diseases. doi: 10.1093/infdis/jiz058. [Epub ahead of print].
Marsden J. Tai B. Ali R. Hu L. Rush A.J. Volkow N. (2019). Measurement-based care using DSM-5 for opioid use disorder: Can we make opioid medication treatment more effective? Addiction. doi: 10.1111/add.14546. [Epub ahead of print].
McDermott M.S. Li G. McNeill A. Hammond D. Thrasher J.F. O'Connor R.J. Cummings K.M. Borland R. Fong G.T. Hitchman S.C. (2019). Exposure to and perceptions of health warning labels on nicotine vaping products: Findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey. Addiction. doi: 10.1111/add.14550. [Epub ahead of print].
McNeill A. Brose L.S. Calder R. Bauld L. Robson D. (2019). Vaping in England, an evidence update, February 2019. A report commissioned by Public Health England. London: Public Health England.
Nahhas G.J. Braak D. Cummings K.M. Heckman B.W. Alberg A.J. Yong H.H. Fong G.T. Boudreau C. Hitchman S.C. McNeill A. (2019). Rules about smoking and vaping in the home: Findings from the 2016 international tobacco control four country smoking and vaping survey. Addiction. doi: 10.1111/add.14579. [Epub ahead of print].
Nielsen S. Murnion B. Campbell G. Young H. Hall W. (2019). Cannabinoids for the treatment of spasticity. Developmental MedicineandChildNeurology. doi: 10.1111/dmcn.14165. [Epub ahead of print].
O'Brien J.W. Grant S. Banks A.P.W. Bruno R. Carter S. Choi P.M. Covaci A. Crosbie N.D. Gartner C. Hall W. Jiang G. Kaserzon S. Kirkbride K.P. Lai F.Y. Mackie R, Marshall J. Ort C. Paxman C. Prichard J. Thai P. Thomas K.V. Tscharke B. Mueller J.F. (2019). A National Wastewater Monitoring Program for a better understanding of public health: A case study using the Australian Census. Environment International. 122:400-411. doi: 10.1016/j.envint.2018.12.003.
O'Connor R.J. Fix B.V. McNeill A. Goniewicz M.L. Bansal-Travers M. Heckman B.W. Cummings K.M. Hitchman S. Borland R. Hammond D. Levy D. Gravely S. Fong G.T. Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey. Addiction. doi: 10.1111/add.14571. [Epub ahead of print].
Richardson S. McNeill A. Brose LS. (2019).Smoking and quitting behaviours by mental health conditions in Great Britain (1993-2014). Addictive Behaviors. 90:14-19. doi: 10.1016/j.addbeh.2018.10.011.
Richmond-Rakerd L.S. Trull T.J. Gizer I.R. McLaughlin K. Scheiderer E.M. Nelson E.C. Agrawal A. Lynskey M.T. Madden P.A.F. Heath A.C. Statham D.J. Martin N.G. (2019). Common genetic contributions to high-risk trauma exposure and self-injurious thoughts and behaviors. Psychological Medicine.49(3):421-430. doi: 10.1017/S0033291718001034.
Sami M. Notley C. Kouimtsidis C. Lynskey M. Bhattacharyya S. (2019). Psychotic-like experiences with cannabis use predict cannabis cessation and desire to quit: a cannabis discontinuation hypothesis. Psychological Medicine.49(1):103-112. doi: 10.1017/S0033291718000569.
Smith C.A. McNeill A. Kock L. Shahab L. (2019). Exploring mental health professionals' practice in relation to smoke-free policy within a mental health trust: a qualitative study using the COM-B model of behaviour. BMC Psychiatry. 19(1):54. doi: 10.1186/s12888-019-2029-3.
Steer C.D. Macleod J. Tilling K. Lim A.G. Marsden J. Millar T. Strang J. Telfer M. Whitaker H. Vickerman P. Hickman M. (2019). The impact of opiate substitution treatment on mortality risk in drug addicts: a natural experiment study. Southampton (UK): NIHR Journals Library; 2019 Jan.
Strang J. Kelleher M. Mayet S. Day E. Hellier J. Byford S. Murphy C. McLennan B. Shearer J. Ryan E. Marsden J. (2019). Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT. Health Technology Assessment. 23(3):1-72. doi: 10.3310/hta23030.
Tompkins C.N.E. Neale J. Marsden J. Strang J. (2019). Factors influencing recruitment to a randomised placebo-controlled trial of oral naltrexone and extended release implant naltrexone: Qualitative study. Journal of Substance Abuse Treatment. 99:52-60. doi: 10.1016/j.jsat.2019.01.012.
West R. Marsden J. Hastings J. (2019). Addiction theories and constructs: a new series. Addiction. doi: 10.1111/add.14554. [Epub ahead of print].
Wilson S. Partos T. McNeill A. Brose L.S. (2019). Harm perceptions of e-cigarettes and other nicotine products in a UK sample. Addiction. doi: 10.1111/add.14502. [Epub ahead of print].
(As of 29th APR 2019)